PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIS vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIS and XLV is -0.72. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-0.7

Performance

BIS vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Nasdaq Biotechnology (BIS) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%500.00%JulyAugustSeptemberOctoberNovemberDecember
-99.60%
452.88%
BIS
XLV

Key characteristics

Sharpe Ratio

BIS:

-0.21

XLV:

0.47

Sortino Ratio

BIS:

-0.06

XLV:

0.71

Omega Ratio

BIS:

0.99

XLV:

1.09

Calmar Ratio

BIS:

-0.07

XLV:

0.40

Martin Ratio

BIS:

-0.38

XLV:

1.38

Ulcer Index

BIS:

19.62%

XLV:

3.74%

Daily Std Dev

BIS:

35.63%

XLV:

10.90%

Max Drawdown

BIS:

-99.77%

XLV:

-39.17%

Current Drawdown

BIS:

-99.71%

XLV:

-11.91%

Returns By Period

In the year-to-date period, BIS achieves a 4.00% return, which is significantly higher than XLV's 2.33% return. Over the past 10 years, BIS has underperformed XLV with an annualized return of -20.64%, while XLV has yielded a comparatively higher 8.97% annualized return.


BIS

YTD

4.00%

1M

4.82%

6M

10.56%

1Y

-4.31%

5Y*

-18.28%

10Y*

-20.64%

XLV

YTD

2.33%

1M

-4.19%

6M

-5.28%

1Y

3.36%

5Y*

7.76%

10Y*

8.97%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIS vs. XLV - Expense Ratio Comparison

BIS has a 0.95% expense ratio, which is higher than XLV's 0.12% expense ratio.


BIS
ProShares UltraShort Nasdaq Biotechnology
Expense ratio chart for BIS: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

BIS vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIS, currently valued at -0.21, compared to the broader market0.002.004.00-0.210.47
The chart of Sortino ratio for BIS, currently valued at -0.06, compared to the broader market-2.000.002.004.006.008.0010.00-0.060.71
The chart of Omega ratio for BIS, currently valued at 0.99, compared to the broader market0.501.001.502.002.503.000.991.09
The chart of Calmar ratio for BIS, currently valued at -0.07, compared to the broader market0.005.0010.0015.00-0.070.40
The chart of Martin ratio for BIS, currently valued at -0.38, compared to the broader market0.0020.0040.0060.0080.00100.00-0.381.38
BIS
XLV

The current BIS Sharpe Ratio is -0.21, which is lower than the XLV Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of BIS and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JulyAugustSeptemberOctoberNovemberDecember
-0.21
0.47
BIS
XLV

Dividends

BIS vs. XLV - Dividend Comparison

BIS's dividend yield for the trailing twelve months is around 2.58%, more than XLV's 1.21% yield.


TTM20232022202120202019201820172016201520142013
BIS
ProShares UltraShort Nasdaq Biotechnology
2.58%1.75%0.00%0.00%0.44%2.10%0.37%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.21%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

BIS vs. XLV - Drawdown Comparison

The maximum BIS drawdown since its inception was -99.77%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for BIS and XLV. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.71%
-11.91%
BIS
XLV

Volatility

BIS vs. XLV - Volatility Comparison

ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 11.55% compared to Health Care Select Sector SPDR Fund (XLV) at 3.45%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
11.55%
3.45%
BIS
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab